Search - tctmd.com

Displaying 401 - 420 of 1470

Sort: Relevancy | Date

Presentation TCT 2018

Most Frequent Errors I See in the Analysis and Interpretation of Trials

Presenter: Peter Juni, Robert W. Yeh

September 23, 2018

Presentation TCT 2018

Case Settled: PCI for Most!

Presenter: Marie-Claude Morice

September 23, 2018

Presentation TCT 2018

Turkey Presents: A Patient With Coronary Thrombus Undergoing Primary PCI for STEMI - Is Stenting Always a Solution?

Presenter: David W.M. Muller, Armando Perez de Prado, Niels van Royen, Nezihi Baris, Rik Hermanides, Raul Moreno, Mark W.I. Webster

September 23, 2018

Presentation TCT 2018

How to Make Trials Larger, Simpler and Less Expensive

Presenter: Peter Juni, Robert W. Yeh, Matthew T. Roe

September 23, 2018

Presentation TCT 2018

Long-Term Outcomes of LM PCI vs CABG: New Insights From the MAIN-COMPARE and IRIS-MAIN Registries

Presenter: Raj Makkar, Patrick W. Serruys, Duk-Woo Park

September 23, 2018

Presentation TCT 2018

Spain Discusses: How Would I Approach This Patient (and Cardiogenic Shock in General)?

Presenter: David W.M. Muller, Armando Perez de Prado, Niels van Royen, Raul Moreno

September 23, 2018

Presentation TCT 2018

Consensus: Considerations In The High Bleeding Risk Patient Requiring PCI And Oral Anticoagulant Therapy

Presenter: George D. Dangas, Giuseppe Tarantini, Roxana Mehran

September 23, 2018

Presentation TCT 2018

LEADERS FREE II: Summary and Clinical Implications

Presenter: Andreas Baumbach, Stephan Windecker, Mitchell W. Krucoff

September 23, 2018

Presentation TCT 2018

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

Presenter: Deepak L. Bhatt, Tullio Palmerini, Michael Maeng

September 23, 2018

Presentation TCT 2018

Case #2 Conclusion: How Did I Actually Treat This Patient?

Presenter: George D. Dangas, Giuseppe Tarantini, Steven R. Bailey, Giovanni Esposito, Juan F. Granada, Roxana Mehran, Francesco Saia

September 23, 2018

Presentation TCT 2018

Ten-Year Outcomes of LM PCI: From the Fu-Wai Left Main Registry

Presenter: Raj Makkar, Patrick W. Serruys, Bo Xu

September 23, 2018

Presentation TCT 2018

How Would I Treat This Patient?

Presenter: George D. Dangas, Giuseppe Tarantini, Ugo Limbruno

September 23, 2018

Presentation TCT 2018

Ultra-Short DAPT (1 3 Months): For Which Patients and Stents Do We Have Evidence?

Presenter: Deepak L. Bhatt, Tullio Palmerini, Philip M. Urban

September 23, 2018

Presentation TCT 2018

Spain Presents: Hemodynamic Support in a Killip IV Class Patient With Acute Myocardial Infarction

Presenter: David W.M. Muller, Armando Perez de Prado, Niels van Royen, Nezihi Baris, Rik Hermanides, Raul Moreno, Mark W.I. Webster

September 23, 2018

Presentation TCT 2018

LM Stenting: New Insights From the DELTA-2 Registry

Presenter: Raj Makkar, Patrick W. Serruys, Alaide Chieffo

September 23, 2018

Presentation TCT 2018

How Would I Treat This Patient?

Presenter: George D. Dangas, Giuseppe Tarantini, Dominick J. Angiolillo

September 23, 2018

Presentation TCT 2018

Introduction

Presenter: David W.M. Muller, Armando Perez de Prado, Niels van Royen

September 23, 2018

Presentation TCT 2018

Patient Selection for Prolonged DAPT: Risk Scores or Wise Clinical Judgement?

Presenter: Deepak L. Bhatt, Tullio Palmerini, Usman Baber

September 23, 2018

Presentation TCT 2018

Sham Controlled Trials for Devices Are Unethical, Unfeasible, and Unnecessary!

Presenter: Ajay J. Kirtane, Stuart J. Pocock, William F. Fearon

September 23, 2018

Presentation TCT 2018

Summary of All the LM PCI vs. CABG Meta-Analyses: Take-Home Messages

Presenter: Raj Makkar, Patrick W. Serruys, Stuart J. Head

September 23, 2018

Advertisement

Most Frequent Errors I See in the Analysis and Interpretation of Trials

Case Settled: PCI for Most!

Turkey Presents: A Patient With Coronary Thrombus Undergoing Primary PCI for STEMI - Is Stenting Always a Solution?

How to Make Trials Larger, Simpler and Less Expensive

Long-Term Outcomes of LM PCI vs CABG: New Insights From the MAIN-COMPARE and IRIS-MAIN Registries

Spain Discusses: How Would I Approach This Patient (and Cardiogenic Shock in General)?

Consensus: Considerations In The High Bleeding Risk Patient Requiring PCI And Oral Anticoagulant Therapy

LEADERS FREE II: Summary and Clinical Implications

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

Case #2 Conclusion: How Did I Actually Treat This Patient?

Ten-Year Outcomes of LM PCI: From the Fu-Wai Left Main Registry

How Would I Treat This Patient?

Ultra-Short DAPT (1 3 Months): For Which Patients and Stents Do We Have Evidence?

Spain Presents: Hemodynamic Support in a Killip IV Class Patient With Acute Myocardial Infarction

LM Stenting: New Insights From the DELTA-2 Registry

How Would I Treat This Patient?

Introduction

Patient Selection for Prolonged DAPT: Risk Scores or Wise Clinical Judgement?

Sham Controlled Trials for Devices Are Unethical, Unfeasible, and Unnecessary!

Summary of All the LM PCI vs. CABG Meta-Analyses: Take-Home Messages

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content